Accredo offers a wide range of medications to treat various complex and chronic conditions. Visit Conditions to learn more about treatment, medications, and support for your condition.
| Medication | Condition(s) | Generic/Biosimilar | Manufacturer |
|---|---|---|---|
| Tretten® (coagulation factor XIII a_subunit [recombinant]) |
Congenital factor XIII A-subunit deficiency
|
Novo Nordisk | |
| Trikafta™ (elexacaftor, ivacaftor and tezacaftor) tablets for oral use, oral granules | Vertex Pharmaceuticals, Inc. | ||
| Triluron™ (sodium hyaluronate) |
Osteoarthritis
|
Fidia Pharma USA, Inc. | |
| Triumeq® (abacavir, dolutegravir, and lamivudine) | Viiv Healthcare | ||
| Trizivir® (abacavir, lamivudine, and zidovudine) | Viiv Healthcare | ||
| Trogarzo™ (Ibalizumab-uiyk) | Theratechnologies, Inc. | ||
| Truvada® (emtricitabine and tenofovir) |
Pre-exposure prophylaxis
|
Biosimilar(s) available, Generic(s) Available | Gilead Sciences, Inc. |
| Truxima® (rituximab-abbs) | Biosimilar | Teva Pharmaceuticals USA, Inc. | |
| Tybost™ (cobicistat) | Gilead Sciences, Inc. | ||
| Tykerb® (lapatinib) |
Breast cancer
|
Generic(s) Available | Novartis Pharmaceuticals Corp. |